Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

USPSTF on Screening for Cervical Cancer

JAMA; 2018 Aug 21; US Preventive Services Task Force

The US Preventive Services Task Force (USPSTF) recommends screening for cervical cancer every 3 years with cervical cytology alone in women aged 21-29 years and screening every 3 years with cervical cytology alone, every 5 years with high-risk human papillomavirus (hrHPV) testing alone, or every 5 years with hrHPV testing in combination with cytology in women aged 30-65 years, according to its new recommendation statement on screening for cervical cancer. The other USPSTF recommendations include:

  • The USPSTF recommends screening for cervical cancer in women < age 21 years.
  • The USPSTF recommends against screening for cervical cancer in women aged >65 years who have had adequate prior screening and are not otherwise at high risk for cervical cancer.
  • The USPSTF recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion or cervical cancer.

Citation:

Kim JJ, Burger EA, Regan C, Sy S. Screening for cervical cancer in primary care. A decision analysis for the US Preventive Services Task Force. JAMA. 2018;320(7):706–714. doi:10.1001/jama.2017.19872.